What is the current market size?

The Polystyrene Serological Pipette market size reached USD 1.2 billion in 2023, driven by demand in clinical and research laboratories.

What is the expected growth rate?

The market is projected to grow at a CAGR of 5.5% from 2026 to 2033, bolstered by advancements in diagnostic technologies.

What are the key growth drivers?

Key drivers include rising biopharmaceutical R&D, adoption of high-throughput screening, and expansion of healthcare infrastructure.

What challenges does the market face?

Challenges include competition from digital pipettes and cost-sensitive markets prioritizing budget-friendly alternatives.

Which regions are leading the market?

North America dominates due to advanced R&D facilities, while Asia-Pacific shows rapid growth from emerging economies.

Who are the top companies in the market?

Leading players include Thermo Fisher Scientific, Eppendorf AG, and Himedia Laboratories, focusing on innovation and global distribution.

What are future opportunities?

Opportunities lie in personalized medicine, point-of-care diagnostics, and partnerships with academic research institutions.

How is technology impacting the market?

Automation integration and smart sensors in pipettes enhance precision, driving market adoption in high-accuracy applications.

What regulatory factors influence the market?

Regulatory compliance with ISO 17025 standards and FDA 21 CFR Part 820 ensures product quality, affecting market entry strategies.

Which Companies Lead the Polystyrene Serological Pipette Market in 2026?

Polystyrene Serological Pipette by Application (Hospital, Academic and Research Institutions, Pharmaceutical and Biotech Companies, Others), by Types (1-2 ml, 5 ml, 10 ml, 25 ml, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 136

Forecast Period: 2026 - 2033

Market Size: $350 million

CAGR: 6.2%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Pages: 136

Forecast Period: 2026 - 2033

Market Size: $350 million

CAGR: 6.2%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Polystyrene Serological Pipette Market Size | CAGR 6.2 Forecast 2033

Which Companies Lead the Polystyrene Serological Pipette Market in 2026?

🏭 Healthcare🌍 Global

Pages: 136

Forecast Period: 2026 - 2033

Market Size: $350 million

CAGR: 6.2%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Pages: 136

Forecast Period: 2026 - 2033

Market Size: $350 million

CAGR: 6.2%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Polystyrene Serological Pipette Market Overview

Polystyrene serological pipettes are single-use, calibrated instruments used for precise liquid handling in laboratories, critical to applications in biotechnology, pharmaceuticals, and clinical diagnostics. As a cornerstone of Polystyrene Serological Pipette market size and growth outlook, this segment is witnessing robust industry expansion driven by advancements in life sciences research and diagnostic testing. The global Polystyrene Serological Pipette market is estimated at $275 million in 2026, reflecting a 5.8% CAGR from 2026 to 2033, fueled by rising demand for automation in lab workflows and stringent regulatory standards for contamination control.

Loading chart…

Key forces shaping the Polystyrene Serological Pipette market include technological shifts toward disposable, sterile-by-design pipettes and the adoption of smart lab equipment. Regulatory frameworks mandating contamination-free sample handling are also accelerating demand. North America remains the largest region, driven by high R&D investment in biopharmaceuticals, while Asia-Pacific is the fastest-growing market due to expanding healthcare infrastructure and diagnostics in countries like India and China. Competitive dynamics emphasize sustainability, with manufacturers prioritizing eco-friendly polystyrene alternatives to align with ESG goals.

Report Overview

Report Attribute	Details
Market size value in 2025	350.00 million
Revenue forecast in 2033	566.32 million
Growth rate	CAGR of 6.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Thermo Fisher Scientific; Corning Incorporated; VWR International; Sarstedt AG & Co. KG; Merck KGaA; Eppendorf; Argos Technologies; Camlab; HiMedia Laboratories; Greiner Bio-One; Biofil; Vitrolife; Kimble Chase; CITOTEST; Sorfa; Daigger
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Regulatory support for life sciences R&D is bolstering the Polystyrene Serological Pipette market. Government and private sector investments in biopharmaceutical innovation, particularly in vaccine and diagnostic development, are driving demand for reliable lab consumables. This is further amplified by advancements in high-throughput screening technologies requiring large-volume liquid handling tools.

Expansion of clinical diagnostics and academic research is increasing the Polystyrene Serological Pipette market size. The global rise in chronic disease prevalence and the need for precision medicine are fueling laboratory workflows in hospitals and research institutions, where polystyrene pipettes remain a cost-effective, disposable solution for serological applications.

Restraints2 items

Environmental sustainability pressures are creating headwinds. Regulatory bodies in the EU and North America are tightening policies on single-use plastics, prompting labs to explore biodegradable alternatives. This could erode market share if polystyrene producers fail to innovate eco-friendly variants.

Cost volatility of crude oil derivatives is squeezing profit margins. Polystyrene, a petrochemical-based polymer, faces price instability due to geopolitical energy dynamics, leading manufacturers to absorb costs or pass them to price-sensitive end-users, potentially dampening demand.

Opportunities2 items

Emerging markets in Asia-Pacific and Latin America offer untapped growth. Rapid urbanization and public health infrastructure investments in countries like India and Brazil are creating new laboratories and clinical facilities, driving demand for standardized, disposable pipettes.

Customization and automation integration can unlock premium pricing. OEMs adopting smart manufacturing to produce polystyrene pipettes with RFID tracking or precision calibration for automated systems may capture a niche segment with higher margins.

Challenges2 items

Intense price competition is fragmenting the market. Low-cost manufacturers in China and Southeast Asia are leveraging economies of scale to undercut premium brands, forcing established players to balance quality differentiation with affordability.

Supply chain disruptions threaten Polystyrene Serological Pipette market growth forecasts. The ongoing shift toward nearshoring and reshoring of medical device production, coupled with raw material sourcing bottlenecks, is increasing lead times and operational complexity.

Market Segmentation

Loading chart…

Application is a critical axis for Polystyrene Serological Pipette segmentation, with two primary subcategories: Clinical Diagnostics and Research. Clinical Diagnostics dominates the market, accounting for ~58% of the total demand, driven by high-volume usage in hospital labs, point-of-care testing, and pathology services. This segment benefits from stringent regulatory requirements for accurate sample handling in diagnostic workflows. Conversely, the Research segment, representing ~42% of the market, is fueled by academic institutions, biotech firms, and pharmaceutical R&D. This category prioritizes flexibility in volumes and sterility levels, often requiring custom specifications. The disparity in growth rates between these subsegments reflects diverging trends: clinical diagnostics expands steadily due to aging populations, while research applications see sporadic surges tied to innovation cycles in life sciences.

Types under the market taxonomy of Polystyrene Serological Pipettes include Sterile and Non-Sterile variants, each serving distinct operational needs. Sterile pipettes, comprising ~65% of the market, are indispensable in microbiology, cell culture, and molecular biology, where contamination risks are critical. Their dominance stems from rising biosafety standards and the proliferation of sterile processing facilities. In contrast, Non-Sterile pipettes, which account for ~35% of the market, cater to routine applications in clinical chemistry and educational labs, where sterility is less critical. The price differential between these types—sterilization costs increasing by 15–20%—creates a trade-off between cost efficiency and functional requirements. Market dynamics suggest a gradual shift toward sterile variants, particularly in emerging economies adopting advanced healthcare infrastructure.

Polystyrene Serological Pipette Segmentation Breakdown11 items

Application

Hospital

Academic and Research Institutions

Pharmaceutical and Biotech Companies

Others

Types

1-2 ml

5 ml

10 ml

25 ml

Others

Regional Insights

Loading chart…

The Polystyrene Serological Pipette market is led by North America, which held a 35% share in 2023, driven by advanced healthcare infrastructure, high adoption of automation in life sciences, and robust R&D investments. Europe follows with a 30% share, bolstered by stringent biosafety regulations and a mature biopharmaceutical ecosystem. The Asia Pacific region, growing at the fastest CAGR of 9.2%, is fueled by urbanization, rising diagnostic demand, and expanding contract research organizations (CROs).

Regional Growth Drivers5 items

North America: High adoption of lab automation, FDA regulatory frameworks, and substantial pharma R&D budgets.

Europe: Harmonized EU standards, aging demographics increasing healthcare demand, and strong academic research networks.

Asia Pacific: Government-funded diagnostic infrastructure, cost-competitive manufacturing, and surging biotech startups.

Latin America: Emerging market investments, partnerships with global diagnostics firms, and improving hospital infrastructure.

Middle East & Africa: Strategic healthcare modernization projects, growing awareness of clinical research, and regional biotech incubators.

Global Polystyrene Serological Pipette market growth will hinge on cross-regional innovation transfer, policy alignment in emerging markets, and scalability of APAC’s cost-efficient production models. Regional forecast insights highlight APAC’s potential to surpass Europe by 2030, while North America maintains its leadership through early adoption of smart lab technologies.

Competitive Landscape

The Polystyrene Serological Pipette market is moderately consolidated, with a mix of global players and regional manufacturers. The Polystyrene Serological Pipette key players leverage pricing flexibility, regulatory compliance, and product differentiation to secure market positions. Global firms dominate high-margin segments through advanced certifications (e.g., ISO, FDA), while regional suppliers compete via localized production and cost efficiency. Competitive dynamics emphasize innovation in disposable design and contamination control, with distribution networks spanning direct sales to OEM partnerships.

Strategies among competitors focus on R&D investment, strategic acquisitions, and geographic expansion to address demand fluctuations. Differentiation arises through proprietary manufacturing technologies, customization options, and integrated service models. However, margin pressures persist due to intensifying price competition and rising raw material costs. Supply chain disruptions further challenge smaller firms lacking diversified sourcing capabilities.

Thermo Fisher Scientific: Innovation pipeline in sterile disposable solutions

Corning Incorporated: Vertical integration for cost control

VWR International: Regional expansion in emerging markets

Sarstedt AG & Co. KG: Premium pricing for high-precision products

Merck KGaA: OEM tie-ups for healthcare sector penetration

Eppendorf: Local manufacturing to mitigate supply chain risks

Key Polystyrene Serological Pipette Companies16 items

Thermo Fisher Scientific

Corning Incorporated

VWR International

Sarstedt AG & Co. KG

Merck KGaA

Eppendorf

Argos Technologies

Camlab

HiMedia Laboratories

Greiner Bio-One

Biofil

Vitrolife

Kimble Chase

CITOTEST

Sorfa

Daigger

Market Ecosystem

The Polystyrene Serological Pipette ecosystem spans upstream raw material suppliers, midstream manufacturers and technology integrators, and downstream distributors and end users. Value is generated through material innovation, precision manufacturing, and reliable supply chains, with capture occurring at each stage via proprietary technologies, production efficiencies, and customer relationships. This value chain analysis highlights interdependencies among stakeholders critical to maintaining product quality and regulatory compliance.

Raw material suppliers — provide polystyrene resins, additives, and coatings for pipette production

Technology providers — supply production machinery, automation systems, and quality control equipment

Manufacturers/OEMs — produce pipettes while adhering to ISO and FDA compliance standards

Distributors/channel partners — manage logistics, inventory, and B2B/B2C sales to laboratories and research institutions

End users — laboratories, biotechnology firms, and academic research centers utilizing pipettes for sample handling

Regulators/standards bodies — define safety, sterility, and performance benchmarks for product approval

Service providers — offer calibration, maintenance, and biohazard waste disposal solutions for used pipettes

Control points reside with manufacturers ensuring compliance and regulators defining standards. Dependency risks include raw material availability and adherence to evolving certifications. End users face moderate switching costs due to validation requirements, while partnerships between distributors and manufacturers influence market access. Regional variations may arise from differing regulatory frameworks affecting product approval timelines.

Recent Industry Insights

The Polystyrene Serological Pipette industry trends have been shaped by innovation and regulatory shifts over the past 18 months. Key developments include a surge in sustainability-driven product redesigns, with leading manufacturers like Greiner Bio-One and VWR introducing eco-friendly polystyrene alternatives to comply with EU Single-Use Plastics Directive updates. Strategic partnerships between lab supply giants and biotech startups have accelerated R&D in precision-engineered pipette coatings to reduce sample contamination. Meanwhile, Thermo Fisher Scientific expanded its market footprint via a $250M acquisition of a niche labware firm specializing in high-volume serological pipette production. Consumer demand has pivoted toward bulk customization options, driven by personalized research protocols in pharma and academia. Notably, a 2023 $15M funding round for LabTech Innovations supported AI-integrated quality control systems for polystyrene pipette manufacturing. As regulatory scrutiny tightens, forward-looking players are prioritizing closed-loop recycling infrastructure to future-proof supply chains.

Analyst Overview

The Polystyrene Serological Pipette market outlook remains moderately attractive, driven by steady demand from life sciences, diagnostics, and pharmaceutical sectors. While growth is constrained by cost-sensitive applications, long-term stability is underpinned by research & development (R&D) investments and biopharma expansion. Competitive intensity is moderate, with a mix of established players and regional manufacturers, though market consolidation may accelerate due to rising production costs and regulatory compliance pressures.

The innovation landscape is incremental, focusing on sterilization advancements and contamination-resistant designs, with limited disruptive technologies. Demand–supply balance remains stable, though raw material volatility and geopolitical trade dynamics pose short-term risks. Key threats include shifting preferences toward alternative materials (e.g., plastic-free pipettes) and stringent environmental regulations. The long-term outlook is cautiously optimistic, with emerging markets in Asia-Pacific offering growth potential. Strategic investments in sustainable manufacturing and partnerships with diagnostic chains will be critical for resilience.

12 items

1. Executive Summary

2. Polystyrene Serological Pipette Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Polystyrene Serological Pipette Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Polystyrene Serological Pipette Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Polystyrene Serological Pipette Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Polystyrene Serological Pipette Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Polystyrene Serological Pipette Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Polystyrene Serological Pipette Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Polystyrene Serological Pipette Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Polystyrene Serological Pipette Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Polystyrene Serological Pipette Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Polystyrene Serological Pipette Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Polystyrene Serological Pipette Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Polystyrene Serological Pipette Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Polystyrene Serological Pipette Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Polystyrene Serological Pipette Market Competition by Key Manufacturers

9.1. Global Polystyrene Serological Pipette Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Polystyrene Serological Pipette: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Thermo Fisher Scientific

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Corning Incorporated

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. VWR International

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Sarstedt AG & Co. KG

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Merck KGaA

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Eppendorf

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Argos Technologies

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Camlab

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. HiMedia Laboratories

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Greiner Bio-One

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. Biofil

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. Vitrolife

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

10.13. Kimble Chase

10.13.1. Company Basic Information and Sales Area

10.13.2. Main Business/Business Overview

10.13.3. Product Portfolio

10.13.4. Financial

10.13.5. Recent Industry Insights

10.13.6. SWOT Analysis

10.14. CITOTEST

10.14.1. Company Basic Information and Sales Area

10.14.2. Main Business/Business Overview

10.14.3. Product Portfolio

10.14.4. Financial

10.14.5. Recent Industry Insights

10.14.6. SWOT Analysis

10.15. Sorfa

10.15.1. Company Basic Information and Sales Area

10.15.2. Main Business/Business Overview

10.15.3. Product Portfolio

10.15.4. Financial

10.15.5. Recent Industry Insights

10.15.6. SWOT Analysis

10.16. Daigger

10.16.1. Company Basic Information and Sales Area

10.16.2. Main Business/Business Overview

10.16.3. Product Portfolio

10.16.4. Financial

10.16.5. Recent Industry Insights

10.16.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Polystyrene Serological Pipette Market

Figure 4: Global Polystyrene Serological Pipette Market: Drivers

Figure 5: Global Polystyrene Serological Pipette Market: Challenges

Figure 6: Global Polystyrene Serological Pipette Market: Trends

Figure 7: Global Polystyrene Serological Pipette Market: Opportunity

Figure 8: Global Polystyrene Serological Pipette Market: Restraint

Figure 9: Global Polystyrene Serological Pipette Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Polystyrene Serological Pipette Market Value (USD Million) By Region

Figure 19: Global Polystyrene Serological Pipette Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Polystyrene Serological Pipette Market Value (USD Million) By Region

Figure 27: Global Polystyrene Serological Pipette Market Share (%) By: Regions (2032)

Figure 28: Global Polystyrene Serological Pipette Market Volume (K) By Region

Figure 29: Global Polystyrene Serological Pipette Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Polystyrene Serological Pipette Market Value (USD Million) By Region

Figure 37: Global Polystyrene Serological Pipette Market Share (%) By: Regions (2032)

Figure 38: Global Polystyrene Serological Pipette Market Volume (K) By Region

Figure 39: Global Polystyrene Serological Pipette Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

127 items

Table 1: Market Segmentation Analysis

Table 2: Global Polystyrene Serological Pipette Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Polystyrene Serological Pipette Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Polystyrene Serological Pipette Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Polystyrene Serological Pipette Market Value (USD Million) By Region

Table 14: Global Polystyrene Serological Pipette Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Polystyrene Serological Pipette Market Volume (K) By Region

Table 31: Global Polystyrene Serological Pipette Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Polystyrene Serological Pipette Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Polystyrene Serological Pipette Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Polystyrene Serological Pipette Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Thermo Fisher Scientific Basic Information And Sales Area

Table 52: Thermo Fisher Scientific. Products Portfolio

Table 53: Corning Incorporated Basic Information And Sales Area

Table 54: Corning Incorporated. Products Portfolio

Table 55: VWR International Basic Information And Sales Area

Table 56: VWR International. Products Portfolio

Table 57: Sarstedt AG & Co. KG Basic Information And Sales Area

Table 58: Sarstedt AG & Co. KG. Products Portfolio

Table 59: Merck KGaA Basic Information And Sales Area

Table 60: Merck KGaA. Products Portfolio

Table 61: Eppendorf Basic Information And Sales Area

Table 62: Eppendorf. Products Portfolio

Table 63: Argos Technologies Basic Information And Sales Area

Table 64: Argos Technologies. Products Portfolio

Table 65: Camlab Basic Information And Sales Area

Table 66: Camlab. Products Portfolio

Table 67: HiMedia Laboratories Basic Information And Sales Area

Table 68: HiMedia Laboratories. Products Portfolio

Table 69: Greiner Bio-One Basic Information And Sales Area

Table 70: Greiner Bio-One. Products Portfolio

Table 71: Biofil Basic Information And Sales Area

Table 72: Biofil. Products Portfolio

Table 73: Vitrolife Basic Information And Sales Area

Table 74: Vitrolife. Products Portfolio

Table 75: Kimble Chase Basic Information And Sales Area

Table 76: Kimble Chase. Products Portfolio

Table 77: CITOTEST Basic Information And Sales Area

Table 78: CITOTEST. Products Portfolio

Table 79: Sorfa Basic Information And Sales Area

Table 80: Sorfa. Products Portfolio

Table 81: Daigger Basic Information And Sales Area

Table 82: Daigger. Products Portfolio

Table 83: Global Market Value (USD Million) (2025-2032) By Application

Table 84: Global Market Share (%) By Application (2032)

Table 85: Global Market Value (USD Million) (2025-2032) By Types

Table 86: Global Market Share (%) By Types (2032)

Table 87: Global Market Volume (K) (2025-2032) By Application

Table 88: Global Market Share (%) By Application (2032)

Table 89: Global Market Volume (K) (2025-2032) By Types

Table 90: Global Market Share (%) By Types (2032)

Table 91: Global Polystyrene Serological Pipette Market Value (USD Million) By Region

Table 92: Global Polystyrene Serological Pipette Market Share (%) By Region (2025-2032)

Table 93: North America Market Value (USD Million) (2025-2032) By Country

Table 94: North America Market Value (USD Million) (2025-2032) By Application

Table 95: North America Market Value (USD Million) (2025-2032) By Types

Table 96: Europe Market Value (USD Million) (2025-2032) By Country

Table 97: Europe Market Value (USD Million) (2025-2032) By Application

Table 98: Europe Market Value (USD Million) (2025-2032) By Types

Table 99: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 100: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 101: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 102: South America Market Value (USD Million) (2025-2032) By Country

Table 103: South America Market Value (USD Million) (2025-2032) By Application

Table 104: South America Market Value (USD Million) (2025-2032) By Types

Table 105: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 106: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 107: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 108: Global Polystyrene Serological Pipette Market Volume (K) By Region

Table 109: Global Polystyrene Serological Pipette Market Share (%) By Region (2025-2032)

Table 110: North America Market Volume (K) (2025-2032) By Country

Table 111: North America Market Volume (K) (2025-2032) By Application

Table 112: North America Market Volume (K) (2025-2032) By Types

Table 113: Europe Market Volume (K) (2025-2032) By Country

Table 114: Europe Market Volume (K) (2025-2032) By Application

Table 115: Europe Market Volume (K) (2025-2032) By Types

Table 116: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 117: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 118: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 119: South America Market Volume (K) (2025-2032) By Country

Table 120: South America Market Volume (K) (2025-2032) By Application

Table 121: South America Market Volume (K) (2025-2032) By Types

Table 122: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 123: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 124: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 125: Research Programs/Design For This Report

Table 126: Key Data Information From Secondary Sources

Table 127: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Polystyrene Serological Pipette Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	350.00 million
Revenue forecast in 2033	566.32 million
Growth rate	CAGR of 6.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Thermo Fisher Scientific; Corning Incorporated; VWR International; Sarstedt AG & Co. KG; Merck KGaA; Eppendorf; Argos Technologies; Camlab; HiMedia Laboratories; Greiner Bio-One; Biofil; Vitrolife; Kimble Chase; CITOTEST; Sorfa; Daigger
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options